BetaGlue
Year
Industry
Oncology
BetaGlue Technologies S.p.A is an Italian clinical-stage oncology company developing a novel radiotherapy platform technology for the localised and targeted treatment of unresectable solid tumours.
A named product ecosystem
BetaGlue needed a product ecosystem with a cohesive, trademarkable ecosystem that made sense to interventional radiologists.
A clinical and bold brand
BetaGlue are a company at the bleeding edge of oncology research, their brand needed to reflect the seriousness, and the detail they deliver.
Heavy on the detail
Like many therapeutics brands, BetaGlue have a lot to say, their communications needed to accommodate long form copy, and clear diagrams.
Building a brand with precision, rigour and order:
BetaGlue Technologies SpA, chose Cohesion Labs to deliver their new and necessary brand, product name ecosystem. presentation and web design. While the team behind the company had worked diligently and passionately on the product, as the treatment began to pick up momentum and show promise at clinical trial, it was clear to incoming CEO, Dr. Colin Story, that the brand did not match the potential and calibre their platform deserved. So they reached out to Cohesion Labs to build a brand, product ecosystem and website to give it the status it deserved.
Our approach.
BetaGlue’s dedication to precision in treatment was evident from our first conversation, inspiring us to create a brand that reflects that meticulous approach. With detailed dives into the mechanics of the technology and extensive research on the treatment itself, we approached BetaGlue’s brand building with the same rigour expected a company that is delivering such game changing tech for people with cancer.
We started with ensuring that the product name and its surrounding components were going to fit intricately and neatly together. After an indepth research and creative process featuring four distinct directions, YntraDose™ was chosen as the winning name that reflected the right notes. The Y, symbolising Yttrium 90 - the isotopic element in the treatment, playing on Intra, “from with”, and Dose - to reflect the precise nature of how they are packaging up their treatment. Secondary to the product name itself, we delivered each of the component parts of the platform, “Guide”. “Glue”, “Dose” and Deliver.
The outcome.
Inspired by Dieter Rams principles - the BetaGlue brand relies on a grid system, our design work utilises a precise grid system paired with a minimal, striking colour palette, aligning perfectly with BetaGlue's environment. The sub-branding for YntraDose further demonstrates this clarity, illustrating the integral role of each component and their collective impact.
For BetaGlue, we developed a minimal, but powerful website that showcased their clinical data, introducing movement and precision throughout. The site now brilliantly shows off the real potential in YntraDose and what it can do for cancer patients, navigating through detailed clinical data, their journey so far, and clear explanations of their technology and pipeline are easy to understand and read.
CEO
|
We have a visual identity that is reflective of who we are
The rebrand is a result of a thorough and diligent process undertaken by our team and the team at Cohesion Labs. We now have a company name, product name, website and visual identity that is reflective of who we are and how our unique platform technology has the potential to provide a new standard-of-care for a wide range of solid tumour cancer patients.
